Claveria-Cabello, A.; Colyn, L.; Arechederra, M.; Urman, J.M.; Berasain, C.; Avila, M.A.; Fernandez-Barrena, M.G.
Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target? Cells 2020, 9, 2321.
https://doi.org/10.3390/cells9102321
AMA Style
Claveria-Cabello A, Colyn L, Arechederra M, Urman JM, Berasain C, Avila MA, Fernandez-Barrena MG.
Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target? Cells. 2020; 9(10):2321.
https://doi.org/10.3390/cells9102321
Chicago/Turabian Style
Claveria-Cabello, Alex, Leticia Colyn, Maria Arechederra, Jesus M. Urman, Carmen Berasain, Matias A. Avila, and Maite G. Fernandez-Barrena.
2020. "Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target?" Cells 9, no. 10: 2321.
https://doi.org/10.3390/cells9102321
APA Style
Claveria-Cabello, A., Colyn, L., Arechederra, M., Urman, J. M., Berasain, C., Avila, M. A., & Fernandez-Barrena, M. G.
(2020). Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target? Cells, 9(10), 2321.
https://doi.org/10.3390/cells9102321